Ion Beam Applications

IBA (Ion Beam Applications SA) is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain (UCLouvain) and became a university spin-off. It employs about 1500 people in 40 locations.[1] The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation.[2]

IBA (Ion Beam Applications)
TypePublic
Euronext: IBAB
IndustryMedical technology
Founded1986 (1986)
FounderYves Jongen
Headquarters
Louvain-la-Neuve
,
Belgium
Area served
Worldwide
Key people
Olivier Legrain (CEO)
Websiteiba-worldwide.com

IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001,[3] and for Philadelphia's Penn Hospital in 2009.[4]

It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom.[5][6]

In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve.[7]

References
  1. "IBA SA - basic data - update following capital increase dated 15 December 2016". Yahoo Finance. 15 December 2016. Retrieved 24 December 2016.
  2. "Ion Beam Applications: IBA". Healthcare Belgium. Retrieved 24 December 2016.
  3. Pearson, Emma; Kleeven, Willem; Nuttens, Vincent; Zaremba, Simon; Van de Walle, Jarno; Forton, Eric; Choo, Robin; Jongen, Yves (2016), Rath, Arabinda Kumar; Sahoo, Narayan (eds.), "Development of Cyclotrons for Proton and Particle Therapy", Particle Radiotherapy, New Delhi: Springer India, pp. 21–35, doi:10.1007/978-81-322-2622-2_3, ISBN 978-81-322-2621-5, retrieved 2022-06-26
  4. Langreth, David Whelan and Robert (2009-02-26). "The $150 Million Zapper". Forbes. Retrieved 2017-07-30.
  5. "BRIEF-Ion Beam Applications signs two contracts with Proton Partners International". Reuters. 13 December 2016. Retrieved 24 December 2016.
  6. "Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment". News medical. 9 December 2016. Retrieved 24 December 2016.
  7. "Un nouveau chapitre pour IBA à Louvain-la-Neuve". Le Soir (in French). 2017-07-11. Retrieved 2022-08-28.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.